We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GVA:NYSEGranite Construction Incorporated Analysis

Data as of 2026-09-21 - not real-time

$115.97

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Granite Construction Incorporated is bearish at $115.97, with short-term averages lagging the long-term ones. The last 30 days have lost 4.6%. RSI sits at 41.6, which reads as neutral, and MACD momentum is bearish. Price has been bracketed by support at $112.70 and resistance at $125.22.
Multiples put this in undervalued territory: 14.5 times earnings against the sector's 27.6. Consensus targets land 48.0% above where the shares trade now. Revenue is growing at 29.3% on a -3.3% profit margin. The 0.45% dividend yield looks covered by current payout levels.
The composite risk read is 5/10, putting it in moderate territory. With 30-day volatility of 31.0%, a beta of 0.87 and a maximum drawdown of 28.9%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Near-term and long-term part ways here — sell short-term against hold longer out, with 1/10 conviction on the long call.

Top Market Events

Construction and construction materials company Granite Construction NYSE:GVA in Q2 CY2026, with sales up 29.Revenue jumps 29% to $1.5 billion as record $7.4 billion capital project backlog and a booming data center business...4dGranite Construction GVA Wins $23.7 Million Road Contract. Can Repeat Work Lift Margins?Granite Construction...

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 5/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 126.87
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 14.5 versus sector average of 27.6
  • Trading below the 200-day average of 126.87

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 14.5 versus sector average of 27.6
  • Negative profit margin of -3.3%
  • Analyst targets imply +48.0% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth29.30%
Profit Margin-3.32%
P/E Ratio14.5
ROE-14.55%
ROA4.73%
Debt/Equity215.12
P/B Ratio6.7
Op. Cash Flow$605.0M
Free Cash Flow$959.0M
Industry P/E27.6

Technical Analysis

TrendBearish
RSI41.6
Support$112.70
Resistance$125.22
MA 20$119.09
MA 50$121.83
MA 200$126.87
MACDBearish
VolumeIncreasing
Fear & Greed Index94.88

Valuation

Fair Value$711.02
Target Price$171.67
Upside/Downside48.03%
GradeUndervalued
TypeGrowth
Dividend Yield0.45%

Risk Assessment

Beta0.87
Volatility30.99%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.